Diabetes, Parkinson's disease
Some Diabetes Drugs May Protect Against Dementia and Parkinson's
Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 diabetes.
Diabetes Drug Linked to 20% Lower Risk of Dementia, Parkinson's
A class of drugs used to treat diabetes has been linked to a 20% lower risk of dementia and Parkinson's disease. | Neuroscience
Some diabetes meds might lower risk of dementia, Parkinson's
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.
Study: Diabetes Drug May Cut Risk of Alzheimer’s and Parkinson’s by 20%
SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, according to a large study. Results showed a 20% to 30% lower risk for these conditions,
Type 2 diabetes drugs could lower dementia, Parkinson's disease risk
Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk of dementia, overall, and of Alzheimer's disease and Parkinson's, in particular.
Diabetes drugs may protect against dementia
New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.
Research shows diabetes drug could reduce dementia risk. Here’s how the two diseases may be linked
Some diabetes medications linked to lower dementia, Parkinson's disease risk
Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By encouraging the kidneys to eliminate sugar from the body through urine, they reduce blood sugar.
New study hopes to unlock cure for Parkinson’s disease
Parkinson’s is the fastest growing neurological condition in the world and affects around 153,000 people in the UK.
New study to investigate non-invasive treatment for dementia and Parkinson’s
A first-of-its-kind study will use ultrasound and light therapies to investigate targeted treatment of Alzheimer’s disease, ...
Groundbreaking new study aims to find cure for Parkinson’s disease
Parkinson’s is the fastest growing neurological condition in the world and affects around 153,000 people in the UK ...
Medscape13d
Frequency, Timing of Dementia in Parkinson's: New Data
A recent study revealed that dementia in Parkinson's disease may occur less frequently or develop over a longer period than ...
Dementia and Parkinson's 'cure' to be investigated in new first-of-its-kind research
A new study by scientists at Nottingham Trent University will use non-invasive techniques to investigate the targeted ...